Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

EQRx No Longer Seeks To Disrupt Prices In Non-Small Cell Lung Cancer Space [Forbes]

EQRx, Inc. (EQRX) 
Company Research Source: Forbes
Alexis Borisy and Melanie Nallicheri pose for a picture inside their office in Cambridge, MA on Jan.... [+]9, 2020. EQRx, a Cambridge startup that debuted in early 2020 pledged something seldom heard from drug makers: dramatically lower prices. However, they've abandoned that plan for now, at least in the non-small cell lung cancer space (Photo by Jessica Rinaldi/The Boston Globe via Getty Images)The biotechnology company EQRx no longer seeks to disrupt prices in the non-small cell lung cancer space. The company had been developing sugemalimab – a PD-(L)1, checkpoint inhibitor – to compete with other drugs in the therapeutic class. But, due to regulatory hurdles and a change in company strategy, EQRx says it is suspending the sugemalimab program. And, for its other products in development it will pursue “market-based pricing” to “maximize shareholder value.”This is disappointing news for those who had hoped for lower prices in a therapeutic category that, for the most part, has been s Show less Read more
Impact Snapshot
Event Time:
EQRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for EQRX alerts
Opt-in for
EQRX alerts

from News Quantified
Opt-in for
EQRX alerts

from News Quantified